Autoimmune neuromyotonia following human papilloma virus vaccination
Corresponding Author
Chiara Cerami MD
Neurological Unit, Department of Clinical Neurosciences, University of S. Raffaele, Milan, Italy
Vita-Salute University and San Raffaele Scientific Institute, Department of Clinical Neurosciences, Via Olgettina, 60 – 20132 Milano, Italy, Tel. 0039 02 2643 5760, Fax. 0039 02 2643 5738. E-mail: [email protected]Search for more papers by this authorMassimo Corbo MD
NEuroMuscular Omnicentre (NEMO), Niguarda Ca’ Granda Hospital, Milan, Italy
Search for more papers by this authorGiovanni Piccolo MD
IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino, Pavia, Italy
Search for more papers by this authorSandro Iannaccone MD
Neurological Unit, Department of Clinical Neurosciences, University of S. Raffaele, Milan, Italy
Search for more papers by this authorCorresponding Author
Chiara Cerami MD
Neurological Unit, Department of Clinical Neurosciences, University of S. Raffaele, Milan, Italy
Vita-Salute University and San Raffaele Scientific Institute, Department of Clinical Neurosciences, Via Olgettina, 60 – 20132 Milano, Italy, Tel. 0039 02 2643 5760, Fax. 0039 02 2643 5738. E-mail: [email protected]Search for more papers by this authorMassimo Corbo MD
NEuroMuscular Omnicentre (NEMO), Niguarda Ca’ Granda Hospital, Milan, Italy
Search for more papers by this authorGiovanni Piccolo MD
IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino, Pavia, Italy
Search for more papers by this authorSandro Iannaccone MD
Neurological Unit, Department of Clinical Neurosciences, University of S. Raffaele, Milan, Italy
Search for more papers by this authorReferences
- 1Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002; 125: 1887–1895.
- 2Rubio-Agusti I, Perez-Miralles F, Sevilla T, Muelas N, Chumillas MJ, Mayordomo F, et al. Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology 2011; 76: 172–178.
- 3Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010; 17: 893–902.
- 4Jaben EA, Winters JL. Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: a report of five cases and review of the literature. J Clin Apher (in press).
- 5Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008; 70: 1883–1890.
- 6Debeer P, De Munter P, Bruyninckx F, Devlieger R. Brachial plexus neuritis following HPV vaccination. Vaccine 2008; 26: 4417–4419.
- 7Bomprezzi R, Wildemann B. Vaccination against human papilloma virus. Neurology 2010; 74: 864–865.
- 8Chang J, Campagnolo D, Vollmer TL, Bomprezzi R. Demyelinating disease and polyvalent human papilloma virus vaccination. J Neurol Neurosurg Psychiatry 2011; 82: 1296–1298.
- 9Sutton I, Lahoria R, Tan I, Clouston P, Barnett M. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 2009; 15: 116–119.
- 10Wildemann B, Jarius S, Hartmann M, Regula JU, Hametner C. Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology 2009; 72: 2132–2133.
- 11Menge T, Cree B, Saleh A, Waterboer T, Berthele A, Kalluri SR, et al. Neuromyelitis optica following human papillomavirus vaccination. Neurology 2012; 79: 285–287.
- 12Myers KA, Baker SK. Late-onset seropositive Isaacs' syndrome after Guillain–Barré syndrome. Neuromuscul Disord 2009; 19: 288–290.